'Vhl' diaporamas de présentation

Roma, 22 febbraio 2013 Highlights in the management of renal cell carcinoma

Roma, 22 febbraio 2013 Highlights in the management of renal cell carcinoma. Clinical and Molecular Predictive factors to molecularly targeted agents: what we know so far.

992 views • 86 slides

Renal cell carcinoma

Renal cell carcinoma. Joby thomas 2002 batch. Epidemiology. RESPONSIBLE FOR 80-85% OF PRIMARY RENAL NEOPLASMS TCC next most common (8%) Incidence increased gradually over past 20 Yrs, probably due to advances in Radiology. Risk factors. Risk factors SMOKING (2 FOLD )

615 views • 53 slides

A few inborn errors

440 views • 25 slides

A few inborn errors

373 views • 25 slides

ADOPTING THE NEW INFORMATION MODEL: CHALLENGES AND ADVANCES

361 views • 23 slides

von Hippel-Lindau Syndrome (VHL)

von Hippel-Lindau Syndrome (VHL). Justin Melton. von Hippel-Lindau Syndrome. Multi-system disorder characterized by abnormal growth of blood vessels. VHL the gene. Tumor suppressor gene Inherited in an Autosomal Dominant fashion Mapped to chromosome 3p25-26 using genetic linkage analysis

682 views • 19 slides

The von Hippel-Lindau (VHL) Tumor Suppressor Gene Inactivation and Its Involvement in Tumorgenesis

395 views • 15 slides

Von Hippel-Lindau Syndrome

Von Hippel-Lindau Syndrome. VHL/HIF1. Meredith Meara 3-30-04. Von Hippel-Lindau Syndrome. VHL is a tumor suppressor. 80% familial 20% sporadic Prevalent in all ethnic groups. What does VHL do?. VHL is very highly conserved evolutionarily

569 views • 12 slides

Von Hippel-Lindau Syndrome (VHL)

317 views • 12 slides

Virtual Health Library in Belize

Virtual Health Library in Belize. VHL initiative launched in October 2003 by PAHO/WHO Belize A means of joining the expanding network of Internet libraries on health sciences information throughout Latin America and the Caribbean

208 views • 6 slides

SUMMARY OF KEY FINDINGS VHL and p53 mutational analysis

Abstract #520 (P31).

86 views • 1 slides

SUMMARY OF KEY FINDINGS VHL and p53 mutational analysis

Abstract #520 (P31).

88 views • 1 slides

147 views • 1 slides

Table 4 VHL alterations as potential predictive markers

Table 4 VHL alterations as potential predictive markers. Gossage, L. & Eisen, T. (2010) Alterations in VHL as potential biomarkers in renal-cell carcinoma Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.42.

136 views • 1 slides